Said Byadi
5PUBLICATIONS
10CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (5)
Sort by Publication Date:
|May 31, 2023
Discovery of a new Bcl-2 inhibitor through synthesis, anticancer activity, docking and MD simulations.Said Byadi, Bimoussa Abdoullah, Mourad Fawzi
|May 20, 2022
Novel isoxazoline-linked 1,3,4-thiadiazole hybrids as anticancer agents: Design, synthesis, biological evaluation, molecular docking, and molecular dynamics simulation.Ali Oubella, Said Byadi, Abdoullah Bimoussa
|Feb 17, 2022
Chemical profiling, cytotoxic activities through apoptosis induction in human fibrosarcoma and carcinoma cells, and molecular docking of some 1,2,3-triazole-isoxazoline hybrids using the eugenol as a precursors.Ali Oubella, Abdelmaoujoud Taia, Said Byadi
|Feb 16, 2022
In silico discovery of novel inhibitors from Northern African natural products database against main protease (Mpro) of SARS-CoV-2.Said Byadi, Domen Oblak, Yassine Kassmi
|Mar 15, 2021
Newly synthesized (R)-carvone-derived 1,2,3-triazoles: structural, mechanistic, cytotoxic and molecular docking studies.Mouhi Eddine Hachim, Ali Oubella, Said Byadi
Pageof 1
Frequent Collaborators
4 joint publications
My Youssef Ait Itto
3 joint publications
Aziz Auhmani
2 joint publications
Mouhi Eddine Hachim
1 joint publications
Lahoucine Bahsis
1 joint publications
Črtomir Podlipnik
1 joint publications
Domen Oblak
1 joint publications
Abdoullah Bimoussa
1 joint publications
Aziz Auhmani
1 joint publications
Hamid Morjani
1 joint publications
Abdelkhalek Riahi
